Venture Capital: Medical Device 'Big Exits' on the Rise

Source: Mass Device (7/23/12)

"The device industry notched 18 'Big Exits,' beating biotech's 17 and extending an upward trend in exit activity in the life sciences, with more than 25 per year since 2009."

Mass Device

Venture-backed M&A activity in 2011 was higher than any other year since 2005, according to a new report tracking trends in life sciences.

The medical device industry in 2011 had 18 "Big Exits," defined as venture-backed acquisitions where the up-front payment totaled $75 million or more.

"Not only has Big Exit M&A activity increased in number, but in up-front value as well," according to the report. "This positive surge in M&A exit activity has created substantial returns to the venture community."

The device industry notched 18 Big Exits, beating biotech's 17 and extending an upward trend in exit activity in the lifesciences, with more than 25 per year since 2009.

"The current environment has paved the way for less structure in device M&A for two main reasons," the report added. "First, the majority of these exits occur with de-risked, post-FDA approved devices where there is really no reason other than commercial uncertainty to structure a transaction. Second, based on the current life science fund-raising environment where distributions are at a premium and are required to raise a new fund, many device investors would prefer to get the immediate gratification of an all-in deal structure paid at deal close and entirely within their control, rather than wait on potential bigger pay-outs based on back-end revenue milestones.". . .View Full Article

Abiomed Shares Gain 8% After Firm Announces Record Q3 Revenue of $232 Million
Source: Streetwise Reports (01/28/2021)

Shares of cardiac medical device maker Abiomed Inc. traded higher after the company reported record revenue for Q3/21 despite the impact from COVID-19.

Avinger Shares Rise 40% on Launch of Image-Guided Device to Diagnose and Treat PAD
Source: Streetwise Reports (01/15/2021)

Shares of Avinger Inc. reached a new 52-week high after the company reported it initiated a full commercial launch of its Tigereye™ Image-Guided CTO Crossing Catheter system for diagnosing and treating peripheral artery disease.

Inari Shares Flow 14% Higher on Triple Digit YoY Growth in Procedures and Revenues
Source: Streetwise Reports (01/13/2021)

Shares of Inari Medical Inc. established a new 52-week high after the company reported that preliminary revenue in Q4/20 increased year-over-year by greater than 140%.

Biotech Collaborates to Advance Psychedelics Use in Cancer, Other Applications
Source: Streetwise Reports (11/23/2020)

Revive Therapeutics enters an agreement with PharmaTher, a specialty psychedelics pharmaceutical firm.

Glaukos Shares Pressured Higher After Firm Reports 11% Rise in Q3 Revenue
Source: Streetwise Reports (11/06/2020)

Shares of Glaukos Corp. traded 9% higher after the company reported Q3/20 financial results that included an 11% YoY increase in glaucoma and corneal health net sales.

Inspire Medical's Shareholders Rest Comfortably on Q3 Earnings and Raised FY Outlook
Source: Streetwise Reports (11/03/2020)

Shares of Inspire Medical Systems traded 30% higher and set a new 52-week high after the company reported Q3/20 financial results that included a 72% rise in YoY revenue.

Shares of Align Technology traded 35% higher and climbed to a new 52-week high after the company reported Q3/20 financial results that included a 20.9% YoY increase in net revenues.

U.S. Medical Device Firm to Acquire Developer of Dissection Stent
Source: Streetwise Reports (09/09/2020)

The specifics of the deal and the next steps for CryoLife are presented in a Ladenburg Thalmann report.

AI Tech Firm Provides COVID-19 Contact Tracing Solution Update
Source: Streetwise Reports (07/20/2020)

Loop Insights continues to educate governments and venue operators around the world about its easily implemented platform.

Announcing Streetwise Live! Events
Source: Streetwise Reports (07/13/2020)

Streetwise Reports is offering 100 investors—at no charge—the opportunity to meet via Zoom with executives of precious metals companies as they discuss recent developments at their companies and upcoming catalysts.